Research location
Framingham
Massachusetts, United States
Advertisement
Research activity in Framingham
Massachusetts, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 40 trials and 42 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Framingham
40 linked trials · page 1 of 1Extracellular RNAs in Relation to Cardiometabolic RiskNCT03225196 · 2017-07-17 · 1 site observation
COMPLETED
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2NCT03225183 · 2017-07-14 · 1 site observation
COMPLETED
Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically SuppressedNCT03110380 · 2017-06-12 · 1 site observation
COMPLETED
A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes MellitusNCT02688933 · 2016-05-05 · 1 site observation
COMPLETED
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)NCT02201992 · 2015-03-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)NCT02193282 · 2015-02-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected AdultsNCT02345226 · 2015-01-26 · 1 site observation
COMPLETED
Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)NCT02345252 · 2015-01-26 · 1 site observation
COMPLETED
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung CancerNCT02152631 · 2014-10-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Metabolic Fuels StudyNCT02235038 · 2014-10-01 · 1 site observation
COMPLETED
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738 · 2014-09-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell CarcinomasNCT02213133 · 2014-09-22 · 1 site observation
TERMINATED
Framingham State Food StudyNCT02068885 · 2014-08-17 · 1 site observation
COMPLETED
A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart FailureNCT02084992 · 2014-06-01 · 1 site observation
COMPLETED
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryNCT01953588 · 2014-02-27 · 1 site observation
ACTIVE_NOT_RECRUITING
In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot UlcersNCT02647346 · 2013-11-01 · 1 site observation
COMPLETED
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerNCT01674140 · 2013-09-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive AdultsNCT01780506 · 2012-12-26 · 1 site observation
COMPLETED
Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot UlcersNCT01693133 · 2012-07-01 · 1 site observation
COMPLETED
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence ScoreNCT01617954 · 2012-05-01 · 1 site observation
COMPLETED
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major DepressionNCT01685294 · 2011-12-01 · 2 site observations
COMPLETED
HIV/STI Risk Reduction for Incarcerated Women With Interpersonal ViolenceNCT01907126 · 2011-09-01 · 2 site observations
COMPLETED
Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)NCT01399619 · 2011-09-01 · 1 site observation
COMPLETED
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerNCT01275677 · 2011-02-08 · 1 site observation
COMPLETED
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based ChemotherapyNCT01168973 · 2010-12-01 · 1 site observation
COMPLETED
A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung CancerNCT00762034 · 2008-12-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Switching From Epzicom to TruvadaNCT00724711 · 2008-07-01 · 1 site observation
COMPLETED
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerNCT00433511 · 2007-11-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryNCT00324805 · 2007-07-19 · 1 site observation
COMPLETED
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryNCT00408408 · 2006-11-01 · 1 site observation
UNKNOWN
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone TherapyNCT00134056 · 2006-08-01 · 1 site observation
COMPLETED
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)NCT00310180 · 2006-04-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Radiation Therapy in Treating Patients With Stage II Prostate CancerNCT00331773 · 2006-04-01 · 1 site observation
COMPLETED
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)NCT00257608 · 2006-01-01 · 1 site observation
COMPLETED
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast CancerNCT00103181 · 2005-03-01 · 1 site observation
COMPLETED
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerNCT00066690 · 2003-12-17 · 1 site observation
COMPLETED
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation TherapyNCT00053898 · 2003-01-01 · 1 site observation
COMPLETED
Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung CancerNCT00048997 · 2002-09-01 · 1 site observation
COMPLETED
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in SituNCT00003857 · 1999-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.